enVVeno Medical Corporation (NVNO)
USD 2.48
(-4.25%)
USD 2.48
(-4.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -546 Thousand USD | -4.0% |
| 2022 | -525 Thousand USD | -15.92% |
| 2021 | -452.9 Thousand USD | -17.95% |
| 2020 | -383.97 Thousand USD | -1328.99% |
| 2019 | 31.24 Thousand USD | -83.25% |
| 2018 | 186.55 Thousand USD | 7508.16% |
| 2017 | 2452.00 USD | 110.06% |
| 2016 | -24.38 Thousand USD | 80.56% |
| 2015 | -125.42 Thousand USD | -220.38% |
| 2014 | 104.18 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -136 Thousand USD | 3.55% |
| 2024 Q1 | -141 Thousand USD | -120.43% |
| 2024 Q3 | -129 Thousand USD | 5.15% |
| 2023 Q2 | -138 Thousand USD | -1.47% |
| 2023 FY | -546 Thousand USD | -4.0% |
| 2023 Q1 | -136 Thousand USD | -4.62% |
| 2023 Q3 | -138 Thousand USD | 0.0% |
| 2023 Q4 | 690 Thousand USD | 600.0% |
| 2022 Q1 | -129 Thousand USD | -6.09% |
| 2022 FY | -525 Thousand USD | -15.92% |
| 2022 Q4 | -130 Thousand USD | 0.0% |
| 2022 Q3 | - USD | 100.0% |
| 2022 Q2 | -133 Thousand USD | -3.1% |
| 2021 FY | -452.9 Thousand USD | -17.95% |
| 2021 Q3 | -120.13 Thousand USD | -11.75% |
| 2021 Q2 | -107.5 Thousand USD | -3.69% |
| 2021 Q1 | -103.67 Thousand USD | -431.84% |
| 2021 Q4 | -121.59 Thousand USD | -1.21% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q4 | 31.24 Thousand USD | 0.0% |
| 2020 FY | -383.97 Thousand USD | -1328.99% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 FY | 31.24 Thousand USD | -83.25% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | -100.0% |
| 2019 Q1 | 31.24 Thousand USD | 103.41% |
| 2018 Q3 | -382.93 Thousand USD | -94.33% |
| 2018 Q4 | -915.04 Thousand USD | -138.96% |
| 2018 FY | 186.55 Thousand USD | 7508.16% |
| 2018 Q1 | 31.06 Thousand USD | -59.73% |
| 2018 Q2 | -197.05 Thousand USD | -734.33% |
| 2017 Q3 | -105.06 Thousand USD | -370.78% |
| 2017 FY | 2452.00 USD | 110.06% |
| 2017 Q1 | -8426.00 USD | -109.07% |
| 2017 Q2 | 38.8 Thousand USD | 560.48% |
| 2017 Q4 | 77.13 Thousand USD | 173.42% |
| 2016 Q2 | -7892.00 USD | 0.0% |
| 2016 Q3 | -101.45 Thousand USD | -1185.58% |
| 2016 Q1 | -7892.00 USD | 0.0% |
| 2016 Q4 | 92.86 Thousand USD | 191.53% |
| 2016 FY | -24.38 Thousand USD | 80.56% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | -125.42 Thousand USD | -220.38% |
| 2014 FY | 104.18 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 82.595% |
| Cerus Corporation | 86.4 Million USD | 100.632% |
| OrthoPediatrics Corp. | 111.25 Million USD | 100.491% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | 173.831% |
| Talis Biomedical Corporation | 371 Thousand USD | 247.17% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 106.601% |
| Inogen, Inc. | 126.69 Million USD | 100.431% |
| Spectral AI, Inc. | 7.88 Million USD | 106.929% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 91.717% |
| CVRx, Inc. | 33.03 Million USD | 101.653% |
| DIH Holding US, Inc. Warrants | - USD | Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | 995.082% |
| Orthofix Medical Inc. | 486.27 Million USD | 100.112% |
| Venus Concept Inc. | 52.16 Million USD | 101.047% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 121.412% |
| Bioventus Inc. | 328.19 Million USD | 100.166% |
| BrainsWay Ltd. | 23.09 Million USD | 102.365% |
| Envoy Medical, Inc. | -473 Thousand USD | -15.433% |
| electroCore, Inc. | 13.22 Million USD | 104.128% |
| IceCure Medical Ltd | 1.3 Million USD | 142.0% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 90.975% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | -1053.456% |
| MaxCyte, Inc. | 36.54 Million USD | 101.494% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | 219.601% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 741.9% |
| PAVmed Inc | -3.96 Million USD | 86.24% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 90.046% |
| RxSight, Inc. | 53.76 Million USD | 101.016% |
| Sight Sciences, Inc. | 69.17 Million USD | 100.789% |
| SI-BONE, Inc. | 109.42 Million USD | 100.499% |
| TELA Bio, Inc. | 40.11 Million USD | 101.361% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 103.433% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 100.359% |
| LivaNova PLC | 771.25 Million USD | 100.071% |
| 908 Devices Inc. | 25.32 Million USD | 102.156% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 100.176% |
| Nemaura Medical Inc. | -1.47 Million USD | 63.018% |
| NeuroPace, Inc. | 48.12 Million USD | 101.135% |
| LENSAR, Inc. | 21.1 Million USD | 102.587% |
| Apyx Medical Corporation | 14.12 Million USD | 103.866% |
| Cutera, Inc. | 41.49 Million USD | 101.316% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 102.958% |
| BioSig Technologies, Inc. | 18 Thousand USD | 3133.333% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 100.53% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 104.011% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 100.061% |
| Axonics, Inc. | 274.55 Million USD | 100.199% |
| Outset Medical, Inc. | 29 Million USD | 101.883% |
| IRIDEX Corporation | 21.8 Million USD | 102.504% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 100.768% |
| IRadimed Corporation | 50.15 Million USD | 101.089% |
| Tivic Health Systems, Inc. | 287 Thousand USD | 290.244% |
| INVO Bioscience, Inc. | 1.08 Million USD | 150.27% |
| Telesis Bio, Inc. | 16.95 Million USD | 103.221% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 100.484% |
| Varex Imaging Corporation | 256.9 Million USD | 100.213% |
| Quipt Home Medical Corp. | 163.84 Million USD | 100.333% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -34.483% |
| Pulmonx Corporation | 50.75 Million USD | 101.076% |
| Dynatronics Corporation | 7.63 Million USD | 107.151% |
| Modular Medical, Inc. | -768 Thousand USD | 28.906% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 109.841% |
| Semler Scientific, Inc. | 61.2 Million USD | 100.892% |
| InMode Ltd. | 411.34 Million USD | 100.133% |
| Bruker Corporation | 1.51 Billion USD | 100.036% |
| Cytosorbents Corporation | 22.39 Million USD | 102.438% |
| DexCom, Inc. | 2.28 Billion USD | 100.024% |
| Align Technology, Inc. | 2.71 Billion USD | 100.02% |
| Viveve Medical, Inc. | 620 Thousand USD | 188.065% |
| ZimVie Inc. | 290.38 Million USD | 100.188% |
| Movano Inc. | -158 Thousand USD | -245.57% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 100.499% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | 741.9% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 100.148% |
| Profound Medical Corp. | 4.51 Million USD | 112.096% |
| Insulet Corporation | 1.15 Billion USD | 100.047% |
| Surmodics, Inc. | 93.05 Million USD | 100.587% |
| iCAD, Inc. | 14.53 Million USD | 103.756% |
| Nuwellis, Inc. | 4.98 Million USD | 110.957% |
| Biotricity, Inc. | 8.35 Million USD | 106.534% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 100.165% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | -52.065% |
| InspireMD, Inc. | 1.8 Million USD | 130.216% |
| PAVmed Inc. | -3.96 Million USD | 86.24% |
| BIOLASE, Inc. | 16.72 Million USD | 103.265% |
| Beyond Air, Inc. | -1.3 Million USD | 58.225% |
| FONAR Corporation | 45.14 Million USD | 101.21% |
| AxoGen, Inc. | 127.87 Million USD | 100.427% |
| Vivani Medical, Inc. | -357 Thousand USD | -52.941% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 100.28% |
| Inari Medical, Inc. | 434.56 Million USD | 100.126% |
| UFP Technologies, Inc. | 112.22 Million USD | 100.487% |
| QT Imaging Holdings, Inc. | - USD | Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | 4461.371% |
| Tenon Medical, Inc. | 1.24 Million USD | 143.997% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | -574.074% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 120.783% |
| AdaptHealth Corp. | 479.56 Million USD | 100.114% |
| Sintx Technologies, Inc. | 1.84 Million USD | 129.626% |
| NanoVibronix, Inc. | 1.53 Million USD | 135.524% |
| Quanterix Corporation | 70.64 Million USD | 100.773% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | -34.483% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 103.883% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 101.034% |
| TransMedics Group, Inc. | 154.09 Million USD | 100.354% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 112.261% |
| NeuroMetrix, Inc. | 3.94 Million USD | 113.832% |
| Hyperfine, Inc. | 4.75 Million USD | 111.478% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 100.51% |
| Biomerica, Inc. | 611 Thousand USD | 189.362% |
| Bone Biologics Corporation | - USD | Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 101.31% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 30.086% |
| Silk Road Medical, Inc | 127.08 Million USD | 100.43% |